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Abstract
Objectives: To report a case of multifocal fibrosclerosis with a nine-year follow up, and to discuss this disease’s
radiological appearance and management. The disease is a rare systemic disorder of unknown cause characterised by
fibrous proliferation involving multiple anatomical sites.
Case report: A 50-year-old woman presented with histological findings characterised by similar inflammatory
processes involving the meninges, pituitary gland, peritoneum, retroperitoneum and orbits, prompting a search for a
common pathophysiology. A diagnosis of multifocal fibrosclerosis was postulated. Symptom improvement was noted
after treatment with prednisone and azathioprine.
Conclusion: This is the first documented case of involvement of the cochleovestibular nerve in a patient with multifocal
fibrosclerosis. The rare association between fibrotic diseases and masses showing various clinical patterns should be kept
in mind by otolaryngologists, and imaging performed to investigate for multifocal fibrosclerosis. However, diagnosis can
only be confirmed with tissue biopsy and histopathological examination.
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Introduction
Multifocal fibrosclerosis is a rare systemic disorder of
unknown cause characterised by fibrous proliferation invol-
ving multiple anatomical sites.1–3 It was first reported by
Bartholomew et al. in 1963.1 The clinical course of the
disease is variable and poorly defined.
To date, few cases of multifocal fibrosclerosis involving
otolaryngological symptoms have been reported. This
paper aims to report a case of multifocal fibrosclerosis with
a nine-year follow up, and to discuss its imaging appearance
and management.
Case report
A 50-year-old woman presented with a long clinical history
of intermittent fever, headache, anaemia, recurrent sinusitis,
30 kg weight loss and seizures. In May 2001, magnetic res-
onance imaging (MRI) of the brain showed frontal and tem-
poral pachymeningitis with invasion of the left cavernous
sinus, sella turcica and left orbital apex, as well as frontal
lobe oedema and pituitary stalk thickening (Figure 1). The
patient underwent the first of two meningeal biopsies,
which showed fibrous connective tissue. The second
biopsy, taken the following year, revealed the presence of
chronic pachymeningitis and a fibrous meningioma, and
the patient underwent 25 sessions of radiotherapy.
In 2004, computed tomography (CT) scanning of the
sinuses showed injury of the apex of the left orbit and
thickening of the ipsilateral optic nerve and the lateral
rectus and superior rectus muscles.
In 2005, the patient started suffering from abdominal pain
and was assessed by CT. The examination was suggestive of
retroperitoneal fibrosis, which was confirmed by laparo-
scopy with multiple biopsies of the peritoneum. Laboratory
evaluation revealed anaemia, an elevated erythrocyte sedi-
mentation rate, elevated C-reactive protein level, elevated
α1-glycoprotein level, decreased albumin level, and normal
levels of serum complement and thyroid-stimulating
hormone. Serological testing was negative for lupus anticoa-
gulant and for Paracoccidioides brasiliensis, aspergillosis
and histoplasmosis. Specific testing for antibodies such as
antinuclear antibodies and anti-neutrophil cytoplasmic anti-
bodies was also negative.
The findings of pachymeningitis and peritoneal and retro-
peritoneal fibrosis led to the search for a common pathophy-
siology for these diseases, and the diagnosis of multifocal
fibrosclerosis was postulated. Thus, treatment with predni-
sone 60 mg (almost 1 mg/kg/day) was initiated, with
azathioprine subsequently added. This treatment enabled
the patient to no longer be hospitalised due to her illness
and to gain weight, thus requiring only out-patient treatment.
In February 2006, the patient was still experiencing head-
aches and started presenting with vertigo, visual haze, diplo-
pia, diabetes insipidus, and gradual hypoacusia in the right
ear with tinnitus. In May 2006, she complained of deafness
in her right ear and hypoacusia in the left ear. A second
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MRI scan showed cochlear and internal auditory canal invol-
vement (Figure 2) that was worse on the right side, involve-
ment of the posterior fossa, and involvement of the right
orbital apex and the ipsilateral optic nerve. However, a
reduction in left orbital apex involvement was observed.
In April 2007, the patient presented with significant
abdominal pain and underwent an abdominal CT scan,
which showed bilateral moderate pyelocalyceal dilatation.
In August 2007, she began to suffer from anosmia.
At her most recent visit, in 2010, the patient presented
with occasional seizures, bilateral deafness, anosmia and
vertigo. Nevertheless, a brain MRI scan did not show any
additional abnormalities compared with her 2006 MRI.
Discussion
The term multifocal fibrosclerosis is used to describe a rare
disease entity of unknown aetiology, which is characterised
FIG. 1
(a) & (b) Axial, postcontrast, T1-weighted magnetic resonance imaging (MRI) scans showing intensive, homogeneous enhancement (arrows) in
the temporal, frontal and interhemispheric regions, indicating thickening of the dura mater. (c) Coronal MRI scan showing frontal and temporal
pachymeningitis (arrows) with invasion of the sella turcica, pituitary stalk thickening (star) and frontal lobe oedema.
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by a variable combination of pathologically similar disorders
that show a fibrotic process infiltrated with blood vessels,
lymphocytes and plasma cells.3 The main presentations of
multifocal fibrosclerosis include retroperitoneal and mediast-
inal fibrosis, sclerosing cholangitis, Riedel thyroiditis and
orbital pseudotumours.1 A number of cases have also been
described involving intracranial fibrosis in the form of
inflammatory pachymeningitis and suprasellar, parasellar
and intrasellar lesions resulting in hypopituitarism or
cranial nerve palsies.1
Depending on the site of involvement, different clinical
features and radiological findings may appear. To the best
of our knowledge, our patient represents the first documented
case of involvement of the cochleovestibular nerve in multi-
focal fibrosclerosis. The patient presented with vertigo and
bilateral, severe sensorineural hearing loss and tinnitus.
Other otolaryngological manifestations included anosmia
and recurrent sinusitis.
The majority of multifocal fibrosclerosis cases seem to be
sporadic. However, some rare reports have described familial
occurrence amongst siblings, suggesting a recessive form of
inheritance.1
Magnetic resonance imaging clearly displays the fibrotic
nature of the lesions found in multifocal fibrosclerosis. On
T1-weighted sequences, lesions may appear as gadolinium-
enhanced, whereas on T2-weighted sequences they are
deeply hypodense.1,2 18F-fluorodeoxyglucose positron emis-
sion tomography imaging can help to establish the diagnosis
of multifocal fibrosclerosis and to evaluate disease activity
and patient response to corticosteroid therapy.1
The diagnosis of multifocal fibrosclerosis is confirmed
with tissue biopsy and histopathological examination.
Lesions show prominent hyalinising collagen bundles, pro-
liferation of myofibroblastic cells, and infiltration by lym-
phocytes.1 The differential diagnosis should include
malignancy, inflammatory pseudotumour and myofibroblas-
tic tumours.1
• Multifocal fibrosclerosis is a rare disorder
involving fibrous proliferation at multiple sites
• Otolaryngological manifestations and
cochleovestibular nerve involvement are possible
• Magnetic resonance imaging clearly shows
fibrosclerotic lesions
• Histopathologically, there are prominent
hyalinising collagen bundles, myofibroblastic
proliferation and lymphocytic infiltration
• Glucocorticoids plus immunosuppressants are
beneficial
Pharmacological therapy with glucocorticoids combined
with immunosuppressant agents (i.e. azathioprine, cyclopho-
sphamide or cyclosporine) has proven beneficial in the treat-
ment of multifocal fibrosclerosis.3 Normalisation of
abnormal laboratory data and improvements in symptoms
and abnormal CT and MRI findings have been noted in
some patients after corticosteroid use, as in the present
patient after prednisone and azathioprine treatment.3 Our
patient gained weight in more recent years and no longer suf-
fered from anaemia; however, her inflammatory marker
levels generally remained increased. Surgical removal and/
or radiation therapy may be considered in the presence of
obstructive or compressive effects of the fibrous masses.1
The rare association between fibrotic diseases and masses
showing different clinical patterns should be kept in mind by
otolaryngologists, and imaging should be performed to
FIG. 2
(a) Axial 3D-FIESTA magnetic resonance imaging (MRI) scan
showing bilateral involvement of the cochlear basal turns
(arrows). (b) Coronal, postcontrast, T1-weighted MRI scan
showing enhancement suggestive of highly fibrotic tissue involving
the meninges (black arrows) and the internal auditory canal (white
arrows). Disappearance of the cerebral sulci in the right hemisphere
is also shown (star).
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document the possible existence of multifocal fibrosclerosis
as the underlying cause.
Conclusion
Multifocal fibrosclerosis is a rare, systemic disorder of
unknown aetiology characterised by a fibrous proliferation
involving multiple anatomical sites. Clinical presentation
can include retroperitoneal fibrosis, mediastinal fibrosis,
sclerosing cholangitis, Riedel thyroiditis and orbital pseudo-
tumours. Less common features are Dupuytren contracture,
Peyronie disease, periaortitis, and fibrosis of the subcu-
taneous tissues, lungs and parotid glands. There can also
be involvement of the cochleovestibular nerve, and other oto-
laryngological manifestations.
Magnetic resonance imaging clearly displays the lesions.
On T1-weighted sequences, lesions may appear as gadoli-
nium-enhanced, whereas on T2-weighted images they are
deeply hypodense. Diagnosis is confirmed by histopatholo-
gical examination, which shows prominent hyalinising col-
lagen bundles, proliferation of myofibroblastic cells, and
infiltration by lymphocytes. Differential diagnoses include
malignancy, inflammatory pseudotumour and myofibroblas-
tic tumours.
Pharmacological therapy with glucocorticoids combined
with immunosuppressant agents (azathioprine, cyclopho-
sphamide or cyclosporine) is beneficial.
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